Careers  |  Sign In  |  Register

Latest in Critical Care

Reuters Health • The Doctor's Channel Daily Newscast

Antenatal steroids boost survival in infants born at 22 weeks gestation

NEW YORK (Reuters Health) – New research from Japan suggests that antenatal corticosteroids promote survival in extremely preterm infants born at 22 to 23 weeks gestation. Based on their observations from a look back at more than 11,000 infants, the clinicians say antenatal corticosteroids “should be...

Reuters Health • The Doctor's Channel Daily Newscast

Glycoprotein IIb/IIIa inhibitors still add benefit in elective PCI

NEW YORK (Reuters Health) - Even with routine use of stents and thienopyridines such as clopidogrel for elective percutaneous coronary intervention, glycoprotein IIb/IIIa inhibitors (GPIs) such as abciximab still provide additional benefit. That’s according to the findings of a meta-analysis reported...

Reuters Health • The Doctor's Channel Daily Newscast

Clopidogrel beneficial after revascularization by CABG following MI

NEW YORK (Reuters Health) – Clopidogrel improves outcomes not only in patients with myocardial infarction undergoing primary percutaneous coronary intervention, but also in MI patients revascularized by coronary artery bypass graft (CABG) surgery, a Danish team has shown. Their findings are reported in...